Literature DB >> 27293260

Measuring Quality of Life in Indian Vitiligo Patients.

Vishal Gupta1, M Ramam1.   

Abstract

Entities:  

Year:  2016        PMID: 27293260      PMCID: PMC4885192          DOI: 10.4103/0019-5154.182435

Source DB:  PubMed          Journal:  Indian J Dermatol        ISSN: 0019-5154            Impact factor:   1.494


× No keyword cloud information.
Sir, We read with interest the recently published article titled, “Dermatology life quality index does not reflect quality of life status of Indian vitiligo patients” by Narahari et al.[1] The authors found that in 54% of their patients, there was no effect or a small effect on quality of life as assessed by dermatology life quality index (DLQI). This did not match their impression of how troubled their patients, as well as Indian patients in general, are due to vitiligo. They concluded that DLQI was not a good measure of the psychosocial impact of vitiligo in Indian patients. This inference would have been more robust if a formal comparison had been made between DLQI and patients’ self-report of disease burden, as has been done by some workers.[23] Alternatively, another validated questionnaire could have been used for comparison.[4] However, their broad point that a disease-specific instrument may be better than a generic one in assessing the impairment in quality of life is generally accepted.[5] Vitiligo impact scale (VIS) and VIS-22 are vitiligo-specific quality of life instruments developed and validated for Indian patients.[36] We conducted a study that compared DLQI and VIS-22 in measuring the quality of life of Indian vitiligo patients and found that while DLQI scores correlated moderately well with the patient-perceived distress, VIS-22 scores showed a strong correlation.[3] These results suggest that though DLQI may be an acceptable alternative, a vitiligo-specific instrument may estimate the psychosocial burden of disease more accurately. Narahari et al.[1] mention certain issues that troubled their patients and stress the need for a culture-specific questionnaire that addresses these and similar concerns. In fact, many of these issues are covered in VIS-22, which was based on a qualitative study using semi-structured interviews of Indian vitiligo patients,[7] supplemented by suggestions from experienced dermatologists and relevant items from other quality of life instruments. The concerns mentioned by Narahari et al.[1] and the corresponding item numbers in VIS-22 include fear of various objects and situations (items 12, 18), suicidal tendency (items 9, 14), marriage prospects (item 20), teasing students in odd names in schools (item 22), and questioning by others (items 3, 8). It would be interesting to learn how useful they find VIS-22 in measuring quality of life in their vitiligo patients.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  6 in total

Review 1.  The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results.

Authors:  M K A Basra; R Fenech; R M Gatt; M S Salek; A Y Finlay
Journal:  Br J Dermatol       Date:  2008-09-15       Impact factor: 9.302

2.  Development and validation of a vitiligo-specific quality-of-life instrument (VitiQoL).

Authors:  Evelyn Lilly; Phoebe D Lu; Judy H Borovicka; David Victorson; Mary J Kwasny; Dennis P West; Roopal V Kundu
Journal:  J Am Acad Dermatol       Date:  2012-02-25       Impact factor: 11.527

3.  Measurement properties of the Vitiligo Impact Scale-22 (VIS-22), a vitiligo-specific quality-of-life instrument.

Authors:  V Gupta; V Sreenivas; M Mehta; B K Khaitan; M Ramam
Journal:  Br J Dermatol       Date:  2014-10-06       Impact factor: 9.302

4.  Vitiligo impact scale: an instrument to assess the psychosocial burden of vitiligo.

Authors:  Gaurang S Krishna; M Ramam; Manju Mehta; V Sreenivas; Vinod K Sharma; Sujay Khandpur
Journal:  Indian J Dermatol Venereol Leprol       Date:  2013 Mar-Apr       Impact factor: 2.545

5.  The psychosocial impact of vitiligo in Indian patients.

Authors:  Pooja Pahwa; Manju Mehta; Binod K Khaitan; Vinod K Sharma; M Ramam
Journal:  Indian J Dermatol Venereol Leprol       Date:  2013 Sep-Oct       Impact factor: 2.545

6.  Dermatology Life Quality Index does not Reflect Quality of Life Status of Indian Vitiligo Patients.

Authors:  S R Narahari; K S Prasanna; M G Aggithaya; K S Bose; T R Praseeda
Journal:  Indian J Dermatol       Date:  2016 Jan-Feb       Impact factor: 1.494

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.